These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 22786805

  • 1. Sample size calculation for the proportional hazards cure model.
    Wang S, Zhang J, Lu W.
    Stat Med; 2012 Dec 20; 31(29):3959-71. PubMed ID: 22786805
    [Abstract] [Full Text] [Related]

  • 2. A novel sample size formula for the weighted log-rank test under the proportional hazards cure model.
    Xiong X, Wu J.
    Pharm Stat; 2017 Jan 20; 16(1):87-94. PubMed ID: 27860138
    [Abstract] [Full Text] [Related]

  • 3. Sample size calculation for mixture cure model with restricted mean survival time as a primary endpoint.
    Li Z, Geng X, Hou Y, Chen Z.
    Stat Methods Med Res; 2024 Sep 20; 33(9):1546-1558. PubMed ID: 39106345
    [Abstract] [Full Text] [Related]

  • 4. Three-component cure rate model for nonproportional hazards alternative in the design of randomized clinical trials.
    Kim HT, Gray R.
    Clin Trials; 2012 Apr 20; 9(2):155-63. PubMed ID: 22353928
    [Abstract] [Full Text] [Related]

  • 5. A unified approach to power and sample size determination for log-rank tests under proportional and nonproportional hazards.
    Tang Y.
    Stat Methods Med Res; 2021 May 20; 30(5):1211-1234. PubMed ID: 33819109
    [Abstract] [Full Text] [Related]

  • 6. Study design of single-arm phase II immunotherapy trials with long-term survivors and random delayed treatment effect.
    Chu C, Liu S, Rong A.
    Pharm Stat; 2020 Jul 20; 19(4):358-369. PubMed ID: 31930622
    [Abstract] [Full Text] [Related]

  • 7. On sample size calculation for comparing survival curves under general hypothesis testing.
    Jung SH, Chow SC.
    J Biopharm Stat; 2012 Jul 20; 22(3):485-95. PubMed ID: 22416836
    [Abstract] [Full Text] [Related]

  • 8. Sample size calculation for testing differences between cure rates with the optimal log-rank test.
    Wu J.
    J Biopharm Stat; 2017 Jul 20; 27(1):124-134. PubMed ID: 26882262
    [Abstract] [Full Text] [Related]

  • 9. Cancer immunotherapy trial design with cure rate and delayed treatment effect.
    Wei J, Wu J.
    Stat Med; 2020 Mar 15; 39(6):698-708. PubMed ID: 31773770
    [Abstract] [Full Text] [Related]

  • 10. Cancer immunotherapy trial design with long-term survivors.
    Ding X, Wu J.
    Pharm Stat; 2021 Jan 15; 20(1):117-128. PubMed ID: 32869945
    [Abstract] [Full Text] [Related]

  • 11. Practical application of cure mixture model for long-term censored survivor data from a withdrawal clinical trial of patients with major depressive disorder.
    Arano I, Sugimoto T, Hamasaki T, Ohno Y.
    BMC Med Res Methodol; 2010 Apr 23; 10():33. PubMed ID: 20412598
    [Abstract] [Full Text] [Related]

  • 12. A clinical trial design using the concept of proportional time using the generalized gamma ratio distribution.
    Phadnis MA, Wetmore JB, Mayo MS.
    Stat Med; 2017 Nov 20; 36(26):4121-4140. PubMed ID: 28815655
    [Abstract] [Full Text] [Related]

  • 13. NPHMC: an R-package for estimating sample size of proportional hazards mixture cure model.
    Cai C, Wang S, Lu W, Zhang J.
    Comput Methods Programs Biomed; 2014 Nov 20; 113(1):290-300. PubMed ID: 24199658
    [Abstract] [Full Text] [Related]

  • 14. Sample size and power for the weighted log-rank test and Kaplan-Meier based tests with allowance for nonproportional hazards.
    Yung G, Liu Y.
    Biometrics; 2020 Sep 20; 76(3):939-950. PubMed ID: 31797363
    [Abstract] [Full Text] [Related]

  • 15. Sample size calculation for the combination test under nonproportional hazards.
    Cheng H, He J.
    Biom J; 2023 Apr 20; 65(4):e2100403. PubMed ID: 36789566
    [Abstract] [Full Text] [Related]

  • 16. Authors' reply to comments on 'Sample size calculation for the proportional hazards cure model'.
    Wang S, Zhang J, Lu W.
    Stat Med; 2015 Jul 30; 34(17):2578-80. PubMed ID: 26133747
    [No Abstract] [Full Text] [Related]

  • 17. Weighted log-rank test for time-to-event data in immunotherapy trials with random delayed treatment effect and cure rate.
    Liu S, Chu C, Rong A.
    Pharm Stat; 2018 Sep 30; 17(5):541-554. PubMed ID: 30058101
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Subgroup detection and sample size calculation with proportional hazards regression for survival data.
    Kang S, Lu W, Song R.
    Stat Med; 2017 Dec 20; 36(29):4646-4659. PubMed ID: 28791726
    [Abstract] [Full Text] [Related]

  • 20. Sample size calculation for studies with grouped survival data.
    Li Z, Wang X, Wu Y, Owzar K.
    Stat Med; 2018 Nov 30; 37(27):3904-3917. PubMed ID: 29888484
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.